Navigation Links
New Dermatological Formula Targets Psoriasis, Eczema and Other Extreme Skin Conditions
Date:9/13/2011

ORMOND BEACH, Fla., Sept. 13, 2011 /PRNewswire/ -- Florida-based SkinHealth Technology introduces a powerful, breakthrough formula that combines cutting-edge cosmeceutical ingredients -- peptides, polysaccharides and botanical emollients -- with a proven skin protectant to help combat even the most serious skin conditions. ExtremeSkinCare Intense Treatment Balm helps reduce the unsightly appearance of psoriasis, eczema, and rosacea and relieve inflamed and irritated skin without steroids.

Millions of Americans are affected by psoriasis, eczema, rosacea or other troublesome skin conditions, leaving them searching for a safe, effective topical treatment.

Dermatologist Jeffrey Parks, MD and a team of skincare experts have developed a formulation containing a perfect combination of ingredients that help reduce inflammation, redness and clear affected skin of plaques.

ExtremeSkinCare Intense Treatment Balm:

  • Helps reduce inflammation, redness, itching and irritation
  • Protects and relieves dry, cracked and scaling skin
  • Increases skin's resistance to further physical damage by 60%
  • Helps improve skin elasticity and stimulates collagen synthesis

SkinHealth Technology LLC, an R&D based development company which formulates advanced dermatological, therapeutic skincare products, was founded in 2008. Jeffrey Parks, MD and a team of skincare professionals develop effective formulas that address bruising, acne, vitamin D deficiency, sun damage and chronic skin conditions.

For more detailed information about ExtremeSkinCare Intense Treatment Balm or to schedule an interview, please contact Jack Surrette at 386.236.9949 or visit http://www.skinhealthtech.com.

Contact:

Jack Surrette
Executive Director
SkinHealth Technology LLC
P.O. Box 731626, Ormond Beach, FL 32173
386.236.9949 or jes@skinhealthtech.com

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE SkinHealth Technology LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBays Novel Aganocide Drugs for Major Dermatological Conditions
2. Pradaxa® (dabigatran etexilate mesylate) Capsules Now on Formulary at Nations Top Heart Hospitals
3. BioLife Solutions Now The Leading Supplier of Pre-Formulated GMP Cryopreservation Media for Umbilical Cord Blood Stem Cells
4. Cerno Bioscience Introduces MassWorks AutoID for Fully Automated Quadrupole MS Formula Determination
5. Parenteral Depots Offer $8 Billion of Reformulation Opportunities and a Strong Competitive Edge in Crowded Pharmaceutical Space
6. Advanced Life Sciences Submits Full Proposal to NIAID for Development of Intravenous Formulation of Restanza as a Biodefense Countermeasure
7. Kibow Biotech Releases Results of Pilot Scale Study of Its Probiotic Formulation for Kidney Health
8. Australian Patent Issued to CreAgri® for Ultraviolet Radiation (UVR) Protection by its Hydroxytyrosol-Based Formulations
9. Biosynthetic corneas formulated with recombinant collagen restore vision and nerve growth
10. Advanced Life Sciences Announces Successful Preclinical Data Supporting Restanza Intravenous Formulation for Hospital Use
11. Maximize Market Research to Improve Formulary Access Within Managed Markets Sector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 23, 2017  In Atlanta, it seems everyone has a ... intertwine to create an expressive and dynamic community unlike any ... and contribute to it. With their newest ... seeks to carry on that tradition with a unique, ... salon is the newest of 13 nationwide locations, ...
(Date:2/23/2017)... INDIANAPOLIS, Ind. (PRWEB) , ... February 23, 2017 ... ... Commercialization Award during the 12th annual Inventors Recognition Reception at Purdue Research ... annually to a faculty member in recognition of outstanding contributions to, and success ...
(Date:2/23/2017)... and SAN FRANCISCO , Feb. 23, ... medicine company, and Beyond Type 1, a not-for-profit advocacy ... diabetes, today announced a grant from Beyond Type 1 ... for type 1 and other insulin-requiring diabetes.  ... developing innovative stem cell-derived cell replacement therapies with a ...
(Date:2/22/2017)... DIEGO , Feb. 22, 2017  PrimeVax Immuno-Oncology, ... will be presenting at the Annual Biocom Global Life ... March 2, at 11:15 AM, at the Torrey Pines ... thankful to the organizers at Biocom who have chosen ... international symposium of biotechnology companies, investors, and clinical researchers," ...
Breaking Biology Technology:
(Date:2/2/2017)...  Central to its deep commitment to honor ... Japan Prize Foundation today announced the laureates of ... envelope in their respective fields of Life Sciences ... being recognized with the 2017 Japan Prize for ... to the advancement of science and technology, but ...
(Date:1/31/2017)...  Spero Therapeutics, LLC, a biopharmaceutical company founded ... bacterial infections, today announced it has acquired a ... Bono Bio Ltd (PBB) to bolster its pipeline ... of Gram-negative bacteria.   The assets acquired have been ... group company. "The acquisition of these ...
(Date:1/26/2017)... -- Crossmatch, a leading provider of security and identity management ... fraud, waste and abuse in assistance operations around the ... Disaster Relief conference in Panama City ... foreign assistance organizations throughout Latin America ... largely unacknowledged problem in the foreign assistance and disaster ...
Breaking Biology News(10 mins):